Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...
TTUHSC researcher Srinivas Nandana, Ph.D., (left) and co-investigator Manisha Tripathi, Ph.D., received a grant from the U.S. Department of Defense to investigate the role of TBX2 in establishing the ...
RECIST was developed in 2000 by the National Cancer Institute, European Organization for Research and Treatment of Cancer, and National Cancer Institute of Canada, with revision to RECIST 1.1 in 2009 ...
When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...
Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow growth and treatment side effects. However, evolving life expectancies prompt ...
May 4, 2010 (Barcelona, Spain) — Monthly infusions of the bisphosphonate zoledronic acid significantly reduce the risk for bone fractures in men with prostate cancer and malignant bone metastases, ...
The White House has not yet responded to TASS' request for comment on the detection of cancer in the former US leader NEW YORK, May 19. /TASS/. Doctors on Friday diagnosed former US President Joe ...
Results suggest bone-protecting agents should be used in patients with metastatic castration-resistant prostate cancer and bone metastasis, especially in the era of androgen receptor pathway ...
For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback